Q&A: A firsthand account of FDA's Pre-Cert Program
Mobi Health News
MARCH 27, 2020
Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.
Let's personalize your content